Global: The Carlyle Group names new operating executive for global healthcare

Global alternative asset manager The Carlyle Group has named former Pfizer chairman and chief executive Ian Read as an operating executive for global healthcare.

“We see increasing opportunities for investments that bring both innovation and efficiency to global healthcare solutions,” said Stephen Wise, managing director and global head of healthcare for The Carlyle Group. “We’re thrilled to welcome Ian to the Carlyle team following his more than 40 years at one of the world’s largest biopharmaceutical companies. We believe his expertise and leadership will support our team in building and growing great companies and finding new investment opportunities across the healthcare spectrum.”

As an operating executive, Read will play an active role in helping Carlyle’s healthcare team find compelling investment opportunities and helping build, grow and transform companies across Carlyle’s global platform.

He will advise Carlyle’s healthcare portfolio company executives and management teams on growth strategies, leadership and talent development, effective operations and risk management.

Read began his career at Pfizer in 1978 and was named CEO in 2010 and chairman of the Pfizer board of directors in 2011. During Read’s tenure as CEO, Pfizer generated a total shareholder return of 250%, achieved 32 FDA approvals for new medicines, invested significantly in R&D, and completed several transformational transactions to help strengthen Pfizer’s pipeline.